IPN Ipsen SA

IPSEN - Buy-back programme - Art 5 of MAR - Week 39 - 2025

IPSEN - Buy-back programme - Art 5 of MAR - Week 39 - 2025

Aggregated presentation by day and by market



Statement of transactions in own shares from September 22nd to September 26th 2025


 


 


 


 


 


 


 
Name of the issue Identity code of the issuer

(Legal Entity Identifier)
Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code)
IPSEN 549300M6SGDPB4Z94P11 22/09/2025 FR0010259150 300 115,90 AQEU
IPSEN 549300M6SGDPB4Z94P11 22/09/2025 FR0010259150 600 116,30 CCXE
IPSEN 549300M6SGDPB4Z94P11 22/09/2025 FR0010259150 300 116,20 TQEX
IPSEN 549300M6SGDPB4Z94P11 22/09/2025 FR0010259150 3400 115,85629 XPAR
IPSEN 549300M6SGDPB4Z94P11 23/09/2025 FR0010259150 275 112,62727 AQEU
IPSEN 549300M6SGDPB4Z94P11 23/09/2025 FR0010259150 1167 113,15596 CCXE
IPSEN 549300M6SGDPB4Z94P11 23/09/2025 FR0010259150 235 112,64681 TQEX
IPSEN 549300M6SGDPB4Z94P11 23/09/2025 FR0010259150 2923 113,84872 XPAR
IPSEN 549300M6SGDPB4Z94P11 24/09/2025 FR0010259150 185 115,08649 AQEU
IPSEN 549300M6SGDPB4Z94P11 24/09/2025 FR0010259150 1013 114,95716 CCXE
IPSEN 549300M6SGDPB4Z94P11 24/09/2025 FR0010259150 148 114,99797 TQEX
IPSEN 549300M6SGDPB4Z94P11 24/09/2025 FR0010259150 3254 115,17560 XPAR
IPSEN 549300M6SGDPB4Z94P11 25/09/2025 FR0010259150 290 111,80 AQEU
IPSEN 549300M6SGDPB4Z94P11 25/09/2025 FR0010259150 1625 111,78258 CCXE
IPSEN 549300M6SGDPB4Z94P11 25/09/2025 FR0010259150 248 111,86774 TQEX
IPSEN 549300M6SGDPB4Z94P11 25/09/2025 FR0010259150 2637 112,50076 XPAR
IPSEN 549300M6SGDPB4Z94P11 26/09/2025 FR0010259150 124 110,76935 AQEU
IPSEN 549300M6SGDPB4Z94P11 26/09/2025 FR0010259150 3476 111,10964 XPAR
        22200 113,67438  

Attachment



EN
30/09/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Ipsen SA

 PRESS RELEASE

IPSEN - Buy-back programme - Art 5 of MAR - Week 39 - 2025

IPSEN - Buy-back programme - Art 5 of MAR - Week 39 - 2025 Aggregated presentation by day and by market Statement of transactions in own shares from September 22nd to September 26th 2025               Name of the issue Identity code of the issuer (Legal Entity Identifier) Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) IPSEN 549300M6SGDPB4Z94P11 22/09/2025 FR0010259150 300 115,90 AQEU IPSEN 549300M6SGDPB4Z94P11 22/09/2025 FR0010259150...

 PRESS RELEASE

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règleme...

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 39 - 2025 Présentation agrégée par jour et par marchéDéclaration des transactions sur actions propres réalisées du 22 Septembre au 26 Septembre 2025       Nom de l'émetteurCode identifiant de l'émetteur (code LEI)Jour de la transactionCode identifiant de l'instrument financierVolume total journalier (en nombre de titres)Prix pondéré moyen journalier d'acquisitionCode identifiant marchéIPSEN549300M6SGDPB4Z94P1122/09/2025FR0010259150300115,90AQEUIPSEN549300M6SGDPB4Z94P1122/09/2025FR0010259150600116,30CCXEIP...

 PRESS RELEASE

IPSEN - Buy-back programme - Art 5 of MAR - Week 38 - 2025

IPSEN - Buy-back programme - Art 5 of MAR - Week 38 - 2025 Aggregated presentation by day and by marketStatement of transactions in own shares from September 15th to September 19th 2025       Name of the issueIdentity code of the issuer (Legal Entity Identifier) Day of the transactionIdentity code of the financial instrument Total daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code) IPSEN549300M6SGDPB4Z94P1115/09/2025FR0010259150300118,40AQEUIPSEN549300M6SGDPB4Z94P1115/09/2025FR0010259150600118,40CCXEIPSEN549300M6SGDPB4Z94P1115/09/2025FR001...

 PRESS RELEASE

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règleme...

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 38 - 2025 Présentation agrégée par jour et par marchéDéclaration des transactions sur actions propres réalisées du 15 Septembre au 19 Septembre 2025       Nom de l'émetteurCode identifiant de l'émetteur (code LEI)Jour de la transactionCode identifiant de l'instrument financierVolume total journalier (en nombre de titres)Prix pondéré moyen journalier d'acquisitionCode identifiant marchéIPSEN549300M6SGDPB4Z94P1115/09/2025FR0010259150300118,40AQEUIPSEN549300M6SGDPB4Z94P1115/09/2025FR0010259150600118,40CCXEIP...

 PRESS RELEASE

Ipsen’s LANTIC Phase II in aesthetics delivers a first-in-class, diffe...

Ipsen’s LANTIC Phase II in aesthetics delivers a first-in-class, differentiated long-acting clinical profile for IPN10200, enabling the initiation of Phase III IPN10200 is a recombinant, first-in-class molecule uniquely engineered to generate increased receptor affinity and internalization that produces a longer duration of action, optimized for safety and efficacyData showed a rapid onset of action, peak effect superior to placebo, and a substantial majority of patients experiencing clinically significant longer duration of effect vs placebo and vs Dysport, defined as a score of “none” or ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch